Pharma and Biotech
EPS Growth shows the relative growth of a company's earnings over the last year.
The rise in total monies receivable for goods / services sold before expenses.
1yr EPS Growth | ![]() |
---|
1yr Revenue Growth | ![]() |
---|
The percentage of the share price that a company pays out as dividends over a year.
The percentage change from the previous year in the dividend paid on each share.
Dividend Yield | ![]() |
---|
1yr DPS Growth | ![]() |
---|
The share price as a ratio of revenue per share.
The share price as a ratio of net asset value.
Price Sales Ratio | ![]() |
---|
Price Book Ratio |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In percentage total change in share price over 30 days.
In percentage total change in share price over 3 months.
Price Chg 30d |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Chg 3m |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The Relative Strength Index measures a share price relative to itself and its recent history.
Momentum is an oscillator that measures the rate of price change.
RSI |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Momentum 20 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Operating Margin is profit as a percentage of sales.
Return on capital employed measures the return from invested and borrowed capital.
Operating Margin | ![]() |
---|
ROCE | ![]() |
---|
Earnings per share, the company's profitability expressed on a per share basis.
Analysts' estimates of future EPS for the next 2 years.
EPS |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Forecast EPS | ![]() |
---|
Monies produced from sales of goods and services after trade discounts, VAT, etc.
Operating Profit is the profit after deducting operating costs from gross profits.
Turnover | ![]() |
---|
Operating Profit Loss |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The difference between current assets and current liabilities.
A current asset representing the company's financial liquidity.
Assets |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cash |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The cumulative amount of stocks sold by company directors over 1 year
The cumulative amount of stocks bought by company directors over 1 year
Sells 1y | ![]() |
---|
Buys 1y | ![]() |
---|
The percentage of stockbrokers that rate the company as a Buy
The percentage of stockbrokers that rate the company as a Hold
Brokers Percent Buy | ![]() |
---|
Brokers Percent Neutral | ![]() |
---|
Currency | UK Pounds |
Share Price | 337.00p |
Change Today | -1.50p |
% Change | -0.44 % |
52 Week High | 1,342.00 |
52 Week Low | 320.00 |
Volume | 11,028 |
Shares Issued | 3.60m |
Market Cap | £12.15m |
RiskGrade | 340 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:23 | 259 @ 327.23p |
15:59 | 312 @ 327.23p |
15:57 | 88 @ 331.61p |
15:18 | 29 @ 339.00p |
13:34 | 293 @ 327.24p |
You are here: research